Women’s Rights Group Cites James’ Stellar Track Record as AG
New York – January 11, 2022 – “Letitia James is a leader who never fails to speak truth to power, and we know she will continue to be an exemplary Attorney General for all New Yorkers. We are thrilled to endorse her because we know she will continue to be a strong champion for women and families across New York and will help move our state forward,” said Sonia Ossorio, President of the National Organization for Women of New York.
Citing her career as a community activist, public servant, legislator, lawyer and leader, NOW points to her accomplishments spearheading reforms for women in the workplace, including paid family leave, voting rights, equal pay, and protecting the rights of New York’s most marginalized communities.
“Letitia James is the best person to continue to lead the agency forward and the critical work she has undertaken to hold drug manufacturers and distributors accountable, unscrupulous individuals who took advantage of New Yorkers during the pandemic, and the powerful gun lobby. Her record as Attorney General is stellar. We want to see her continue to fight on behalf of New Yorkers,” Ossorio added.
Under James’ leadership, the Attorney General’s Office delivered to New York communities most impacted by the opioid crisis, $1.5 billion in funds recovered from drug manufacturers and distributors for their role in fueling the opioid epidemic. During the Covid-19 pandemic, she fought for New York’s most vulnerable citizens and ensured New Yorkers were protected from predators seeking to profit from the worst pandemic in our lifetime. In addition, she took on the National Rifle Association and is in the midst of a major investigation into the Trump Organization.
NOW-NY advocates for laws that defend our rights and break barriers for women and girls. We work to advance economic opportunity and fairness in the workplace, protect and expand reproductive rights, and strengthen our criminal justice system for victims of gender-based violence.
###
Press inquiries: 212-627-9895 | [email protected]